Skip to main content
. 2011 Jun;6(6):1393–1399. doi: 10.2215/CJN.10521110

Table 4.

Incidence rate of leukocyte spike events by presence or absence of CKD

Event Annual Incidence Rate
Non-CKD (95% CI) CKD (95% CI) Unadjusted IRR (95% CI) P for IRR Adjusted IRR (95% CI) P for IRR
Total leukocyte count increase > 11.5 K/μl 1.09 (0.93, 1.26) 1.95 (1.78, 2.12) 1.78 (1.50, 2.11) <0.001 1.98 (1.63, 2.41) <0.001
Absolute granulocyte count increase > 8.6 K/μl 0.81 (0.68, 0.95) 1.43 (1.28, 1.58) 1.76 (1.44, 2.14) <0.001 2.08 (1.66, 2.62) <0.001
Absolute eosinophil count increase > 0.45 K/μl 0.56 (0.45, 0.68) 1.80 (1.63, 1.96) 3.19 (2.55, 4.00) <0.001 2.29 (1.79, 2.94) <0.001
Granulocyte (%) increase > 70% 2.25 (2.02, 2.48) 6.03 (5.73, 6.34) 2.68 (2.39, 3.00) <0.001 2.60 (2.29, 2.96) <0.001
Lymphocyte (%) decrease < 18% 2.90 (2.64, 3.16) 8.44 (8.08, 8.80) 2.91 (2.64, 3.22) <0.001 2.82 (2.53, 3.15) <0.001
Monocyte (%) increase > 11% 2.09 (1.86, 2.31) 5.86 (5.56, 6.16) 2.81 (2.50, 3.16) <0.001 2.68 (2.35, 3.06) <0.001
Eosinophil (%) increase > 3% 1.14 (0.98, 1.31) 3.12 (2.90, 3.34) 2.73 (2.32, 3.20) <0.001 2.08 (1.74, 2.49) <0.001
Basophil (%) increase > 2% 0.54 (0.43, 0.65) 1.31 (1.17, 1.45) 2.43 (1.92, 3.08) <0.001 2.07 (1.58, 2.71) <0.001

Multivariate adjusted for age, gender, race, diabetes, smoking, ACEI or ARB use, statin use, and BP medication use. IRR, incidence rate ratio.